Amarin Corporation plc (AMRN) Stock Price & Analysis
Amarin Corporation plc (AMRN) closed at USD 11.57 on Thursday, October 15, 2026, down 0.34% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 11.61; the Oct 15, 2026 session ranged USD 11.56–11.85 on volume of 54,355 shares. Market capitalization is $244.39M, with a 52-week range of USD 11.34–20.9 (NCM). Source: Nexqual, retrieved October 16, 2026 at 05:19 UTC.
Also available as compact Markdown for AI agents: nexqual.com/AMRN.md
Key facts (AMRN)
- Analysts: Strong Sell (mean 4.50 on a 1–5 scale) (2 analysts), mean target USD 12.5 (range 12–13).
- Total return with dividends: 1Y -42.4% vs S&P 500 +18.1%; 5Y -88.8% vs S&P 500 +85.1%.
- Next earnings: 2026-10-28, EPS estimate USD -0.02, revenue estimate $43.7M.
Analysts (AMRN)
Consensus Strong Sell (mean 4.50 on a 1–5 scale), 2 analysts; mean target USD 12.5 (low 12, high 13).
Total return (dividends reinvested) (AMRN)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -42.4% | -88.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -42.5% | -35.4% |
| Volatility (annualized) | 41.6% | 69.5% |
| Max drawdown | -43.1% (Oct 2025→Oct 2026) | -92.3% (Oct 2021→Mar 2025) |
Key Statistics (as of October 16, 2026 at 05:19 UTC)
| Price | USD 11.57 |
|---|---|
| Change | ▼ 0.34% (down) |
| Previous Close | USD 11.61 |
| Open | USD 11.57 |
| Day Range | USD 11.56 – 11.85 |
| 52-Week Range | USD 11.34 – 20.9 |
| Volume | 54,355 shares |
| Market Cap | $244.39M |
| Exchange | NCM |
Technical Analysis (AMRN)
Nexqual's technical model rates AMRN "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 16, 2026 at 05:19 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 21.27 (oversold) |
| vs SMA50 | Below (USD 13.46) |
| MACD | -0.59 (negative) |
Analyst Ratings (AMRN)
Wall Street analysts rate AMRN "Strong Sell" based on 2 analysts, with a mean price target of USD 12.5 (range USD 12–13), per Nexqual as of October 16, 2026 at 05:19 UTC.
| Consensus Rating | Strong Sell |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 12.5 |
| High Target | USD 13 |
| Low Target | USD 12 |
| Buy / Hold / Sell | 0 / 0 / 2 |
Earnings (AMRN)
| Next Earnings Date | 2026-10-28 |
|---|---|
| Revenue Estimate | $43.71M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.02 vs est -0.01 ▼ miss |
| 2026-03-31 | USD 0 vs est 0.17 ▼ miss |
| 2025-12-31 | USD 0.01 vs est 0.07 ▼ miss |
| 2025-09-30 | USD 0.19 vs est 0 ▲ beat |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Financials & Fundamentals (AMRN)
| Total Revenue | $186.23M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -42.00% |
| Gross Margin | +41.96% |
| Operating Margin | -28.36% |
| Profit Margin | -14.56% |
| ROE | -5.97% |
| Debt / Equity | 0.02 |
| Current Ratio | 3.67 |
| Total Cash | $314.65M |
| Total Debt | $7.17M |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Financial Health Score (AMRN)
Nexqual rates Amarin Corporation plc's overall financial health "Mixed" across five dimensions, as of October 16, 2026 at 05:19 UTC.
| Growth | Weak — Revenue -7% YoY (annual), declining |
|---|---|
| Profitability | Mixed — Gross margin 42%, operating -28% |
| Balance Sheet | Strong — $315M cash vs $7M debt, net cash position |
| Cash Flow | Solid — Operating cash flow $16M (TTM) |
| Efficiency | Critical — ROE -6%, ROA -2.3% |
Ownership (AMRN)
| Insider Ownership | +37.19% |
|---|---|
| Institutional Ownership | +20.78% |
| Shares Outstanding | 21.12M |
| Float | 19.41M |
| Short % of Float | +2.55% |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Leadership (AMRN)
Amarin Corporation plc is led by Aaron D. Berg (age 62), CEO, President & Director, per Nexqual as of October 16, 2026 at 05:19 UTC.
| CEO, President & Director | Aaron D. Berg (age 62) |
|---|---|
| Senior VP & CFO | Peter L. Fishman (age 41) |
| Executive VP & Chief Operating Officer | David Keenan (age 57) |
| Executive VP, President of Research & Development and Chief Scientific Officer | Steven B. Ketchum (age 60) |
| Senior Vice President of Corporate Development | Eric Boothe |
Major Backers & Investors (AMRN)
Notable institutional backers of Amarin Corporation plc include Sarissa Capital Management, LP, Acadian Asset Management. LLC, Kynam Capital Management, LP, according to Nexqual as of October 16, 2026 at 05:19 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Sarissa Capital Management, LP | 7.92% |
| Acadian Asset Management. LLC | 3.41% |
| Kynam Capital Management, LP | 2.52% |
| Morgan Stanley | 1.06% |
| Waterfront Wealth, Inc. | 1.01% |
| Brooklands Fund Management Ltd | 0.84% |
| Eversept Partners, LP | 0.69% |
| Millennium Management | 0.55% |
Source: Nexqual, October 16, 2026 at 05:19 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OGN | Organon & Co. | USD 13.76 | ▼ 0.07% |
| GRFS | Grifols, S.A. | USD 7.54 | ▲ 5.16% |
| BIIB | Biogen Inc. | USD 235.35 | ▲ 2.82% |
| SNY | Sanofi | USD 40.29 | ▲ 2.99% |
| GSK | GSK plc | USD 49.02 | ▲ 5.94% |
| BMY | Bristol-Myers Squibb Company | USD 60.57 | ▲ 6.88% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:19 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt